chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Cannot take a deep breath in/Not able to breath in; chest tightness; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Cannot take a deep breath in/Not able to breath in) and CHEST DISCOMFORT (chest tightness) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced DYSPNOEA (Cannot take a deep breath in/Not able to breath in) and CHEST DISCOMFORT (chest tightness). At the time of the report, DYSPNOEA (Cannot take a deep breath in/Not able to breath in) and CHEST DISCOMFORT (chest tightness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
In the Morning after my shot, I was getting breakfast ready for my kids. Everything seemed fine at the time and I started getting an odd feeling. Not really a dizzy or lightheaded feeling, but an odd feeling. The next thing I know, I came to on the floor. My security camera in the living room caught part of it from down a hall. I fell strait forward, onto my stomach with a large crash. The rest of the day, I did feel fatigue, joint pain in my knees and then chills/hot flashes later in the day/evening. The next morning (Friday) I woke up with a scratchy throat but felt fine the rest of the day.  I  have never fainted in the past. I don't know what would bring that on.  I also have not had that feeling or any fainting spells since that incident. My wife came home about 8am out of concern.
Swelling on face. Shortness of breath. Rash-hives within 20 minutes.
A non-serious spontaneous report of administration of expired product was received from a health professional concerning a five-year-old male. Neither the patient's past medical history nor the concomitant medications were reported. The product expired on 02-Dec-2010. The patient received the expired FLUMIST on 10-Dec-2010.There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved.
vitreous detachment; 5 hemorrhages in her eye/hemorrhage on the eye (retina); This is a spontaneous report from a Pfizer Sponsored Program  received from a contactable pharmacist (patient). A female patient of an unspecified age received bnt162b2 (BNT162B2 reported as PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 05Mar2021 (Batch/Lot number was not reported) as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. She mentioned that she got her first dose vaccine on 05Mar2021 at pharmacy. The patient reported that two weeks and two days after (21Mar2021), she experienced vitreous detachment, her vitreous detached from the retina and she already had had 5 hemorrhages in her eye. She mentioned that her second dose is due on Friday, 02Apr2021 and she requested information on this specific side effect to make an informed clinical decision on whether or not to get her second dose of the vaccine this Friday. She mentioned that she does not know if this happened because of the vaccine or not. She added that she had a hemorrhage on the eye (retina). The outcome of the events was unknown.   Information on lot/Batch number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported vitreous detachment and retinal haemorrhage.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
When was injected with the fvizer shot if I spelled that correctly, the first one that is , I do not intend to get the second. It caused my wrist , forearm and fingers to go numb and im still having problems. I drop things all the time and even droped a knife last week and almost got injured. I have not been sleeping well and wake up at night sweating some times, I have gone to my primary care medical doctor, accupuncturist and NAET practitionary for therapy and chiropractor. I will go to message therapy as will which has been recommended by my MD but is not covered by my insurance unlike accupuncture and chiropractic. THe NAET and message is out of pocket and expensive. I still to this day have the swelling and numbness of the arm and hand of which i got injected in. I have to be very careful not to use that hand when carrying certain thing to prevent spilling or droppingthe item and causing further damage. Plan to go back to MD this week for followup this week and need to go to my neurologist to make complaint and get treatment. Prior to getting the shot, Docotora recommended I do not get the vaccine because of being autisitic and having a history of allrgies and a over reactive immune system. Mother told me my autism was a reaction to a vaccine when a baby or little boy, and there were zero symptoms prior. She was very upset when finding out i got the vizer corona 19 virus vaccine and that I should have listened to my doctors.
First shot was feel little bit pain; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified gender and age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: EW0172) via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date when confirmed that the patient got the adverse reaction after the second shot, he stated that yeah, the second shot was the problem, first shot was little bit pain. The outcome of event was unknown.
Patient recieved their second dose of Pfizer vaccine on 8/30/21 and presented to the ED on 9/2/21 with complaints of chest pain. Ultimately patient has mild pericarditis with an elevated troponin of 0.499.
Severely swollen lymph nodes in armpit and chest on side of injection for 48 hours (unresolved at this time) Fever 100.5-100.9 x 30 hours Severe muscle and bone aching  x 36 hours Chills x  18 hours
Fever, Chills, Body Aches, Tired  14 Hours Post vaccine: Woke up with Nauseous and stomach cramps. I fainted and hit my head twice landing. My husband heard and ran to the bathroom. He held me and I fainted again in his arms. He called 911, while the medics were on the way I threw up very dry and hard throw up. I started to feel a little better after that. Medics said everything looked ok and did not take me to the hospital. The following morning we went to the hospital, got a cat scan and everything luckily came up fine. Currently, I have a terrible ear ringing and muffledness from the concussion.
2 minutes after vaccine was administer, pt complaint of metallic taste in her mouth and some tingling on her gums- pt stayed in the pharmacy waiting area for 1 hour to make sure that her symptoms didn't worsen-- after 1 hour, she reported that she s feeling fine, "no more metallic and tingling sensation  in her mouth". she was advised to  get to ER immediately if she doesn' t feel well at home.
FEEL LIKE CRAP; WIPED OUT; This spontaneous report received from a consumer via other manufacturer (Novavax) concerned a male of unspecified age, race and ethnic origin. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (dose number in series 1) (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose not reported, 1 total administered on an unspecified date for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient received booster dose of covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose not reported, 1 total administered on an unspecified date for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, after the booster shot, the patient was wiped out and felt like crap (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the wiped out and feel like crap was not reported. This report was non-serious.
Information has been received from a registered nurse concerning a male patient who in September 2003, was vaccinated IM with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 647681/0986N). It was reported that currently the patient had experienced pneumonia infection. Unspecified medical attention was sought.
pt recv varivax 8/7/96 & in 5/98 devel varicella w/approx 50 vesicles. the rpt m.d. felt that varicella was not related to therapy w/varivax
Site of inoculation was bright red, hot and slightly swollen it measured about 5 inches. I also had a rash continuing down my arm past the red ares and on my back from top to just above my waist
No additional adverse event; Caller reported vaccine administered after temperature excursions.; This spontaneous report was received from a medical assistant regarding to a patient of unspecified age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 17-AUG-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml, lot #W012166, expiration date: 12-APR-2024, administered subcutaneously (SQ), (strenght was not provided) as prophylaxis (Product storage error).  The improperly stored vaccine underwent a temperature excursion of 10.9 degrees Fahrenheit (F) for 5 hours and 30 minutes without previous excursions.   This is one of several cases received from the same reporter.; Sender's Comments:  US-009507513-2209USA000179: US-009507513-2209USA000350: US-009507513-2209USA000177: US-009507513-2209USA000361: US-009507513-2209USA000374: US-009507513-2209USA000438: US-009507513-2209USA000437:
1)Hives - On December 27th (13 days after my booster) I broke out in hives all over my body. This was terrible for approx 3 weeks, but I was able to control it with over the counter antihistamines taken every other day. After 3 weeks the hives got somewhat better and I was able to take the antihistamines once every 4 days. It has now been 5 weeks since the hives started. It has not gone away and I am still taking the antihistamines once every 4 days.  I have never had any issues with allergies before this.  2)Tinnitus - Around the same time (Dec 27th), I started to notice Tinnitus in both ears. I have never experienced this before. Over time, it seems that the Tinnitus has gotten worse. It is now February 7th, 2022 and it is very strong and annoying. The Tinnitus is constant all day and night long.
Heart became tachycardic ( 140 - 160 beats/min) then It would become bradycardic (50 beats/min) and sometimes skip a beat. During this time, I was short of breath and had blurry vision. I also experienced tremors of both hands. This lasted approximately 15 minutes before bedtime at 10:30pm the SAME day I received the shot. Heart rate and SpO2 was measured by pulse oximetry and palpitating pulses.  SpO2 would go from about 85% to 100% on room air.
pt recvd vax 13OCT94 @ 1015AM; tempra given 1PM; to ER 7PM 13OCT94 inconsolable crying x 3 hrs, t102 R Advil given;
Received 1st dose then tested positive for COVID 19; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Received 1st dose then tested positive for COVID 19) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Received 1st dose then tested positive for COVID 19). At the time of the report, SARS-COV-2 TEST POSITIVE (Received 1st dose then tested positive for COVID 19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment information was not provided.
Very Very sick. Ache for 3 days severe first and second shot. Eventually went away but this needs to be reported!!!! I hated it
2 inch pink spot at injection site. Firmness & hot skin at injection site. No treatment necessary.
Employee given TB screening with Tetanus injected instead of PPD. Local reaction to left forearm around 10 cm diameter with 1 cm raised lesion in center. Complained of pain at site. No specific treatment given.
15 minutes after the shot I passed out in my car.; syncope; hypomagnesemia; abnormal EKG; This is a spontaneous report from a contactable consumer (patient). A 32-year-old female patient received first dose of bnt162b2 (BNT162B2, solution for injection, Lot Number: EW0196), dose 1 via an unspecified route of administration, administered in Arm Left on 13Jun2021 12:00 (age at the vaccination 32-year-old) as single dose for covid-19 immunization. Medical history and concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 13Jun2021, the patient had an adverse event which she described as "15 minutes after the shot I passed out in my car on 13Jun2021 12:15, syncope on 13Jun2021 12:15, hypomagnesemia on 13Jun2021 12:15, abnormal ekg on 13Jun2021 12:15."  Seriousness Criteria-Persistent, AE required visit to the emergency room. The patient underwent lab tests and procedures which included electrocardiogram: abnormal.  The outcome of the events was recovering.  Follow up attempts are completed. No further information expected.
6h after dose, had two 20-30 min nose bleeds, then two more lasting 30-45min by 5:00pm the next day (4/13/21) She had a slight headache right after administration and took acetaminophen and her headache was relieved in 10min. She has not had any NSAIDs or other medications or OTC products.
This spontaneous report was received from a pharmacist via company representative refers to a patient of unknown age and gender. The patient pertinent medical history and drug allergies/reactions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX (strength 19400 PFU) (dosing details, anatomical location, lot# and expiry date unknown). On an unknown date approximately in 2014 (reported as about 2 years ago) the patient developed shingles after receiving the vaccination. The outcome of the event was unknown. The reporter did not provide the relatedness of the event with ZOSTAVAX. No VZVID pack was sent as the administering healthcare provider was unknown. No product quality issue was involved. Additional information has been requested.
Very sore arm began almost immediately after the vaccine was administered.  In the evening I started to have chills which have continued today.  Additionally I have a severe headache.
Patient received her immunization and within 5 minutes collapsed and stopped breathing. When she began breathing again she was very pale and complained of abdominal pain and had dilated pupils. After a few more minutes of observation and drinking orange juice she began feeling fine again and had no abnormal chest or heart sounds.
Given too soon.  Explained to mom that the dose would not count and that she should return in January for valid dose #3.  Child tolerated the vaccine well without issues.
Seen in office 6/27/11 for evaluation of urticaria. Mild and gradually worsening past 2 days. Multiple exposures for the first time including peanut butter and almonds. Immunization for hepA and DTaP day before hives developed. Skin with diffuse, red, raised urticarial lesions. Eyes/mouth normal. No other sx.
Vaccination rec. 11/13/2010 at 3:30 PM pt experienced muscle & joint discomfort, itchy & painful skin all over. Gastrointestinal complaints gas etc. Had chills unknown if there was fever, did not feel like eating until 11/14/10 in evening.
Constant headache/migraine; Constant headache/migraine; Panic; Trouble sleeping; Chest pain; Fatigue; Trouble breathing; Feeling of doom; This is a spontaneous report from a contactable other healthcare professional (patient). A 37-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: Not reported) via intramuscular, in left arm on 18Jan2021 as single dose for COVID-19 immunization (at the age 37 years). Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via intramuscular on left arm on 28Dec2020 as single dose for COVID-19 immunization (at the age 37 years). The patient medical history and concomitant medications were not reported. Most recent COVID-19 vaccine was administered in Hospital. No other vaccine was received 4 weeks prior and no medication was received prior 2 weeks. Patient was not diagnosed with covid-19, prior to vaccination and since the vaccination the patient was not been tested for COVID-19. Patient did not have allergies to medications, food, or other products. On 19Jan2021, patient experienced constant headache/migraine, panic, trouble sleeping, chest pain, fatigue, trouble breathing and feeling of doom. Patient visited Physician's office for the treatment. No treatment was received in response to events. The outcome of the event was not recovered.  Information on the lot/batch number has been requested.  Follow-up (15-Apr-2021): This follow-up is being submitted to notify that the batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Pt called reported adverse event , 2 days after getting covid booster that her arm is in a lot of pain and can barely lift it up.  Stated she went to dr and they gave her lidocaine cream and muscle relaxers. It is still on going and can not use her left arm to do anything.
Three hours after receiving GARDASIL #1 hands became swollen and painful x 12 hours.
Non-Hodkin Lymphoma; This case was reported by a other health professional via call center representative and described the occurrence of non-hodgkin's lymphoma in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (unknown). On an unknown date, unknown after receiving Shingrix, the patient experienced non-hodgkin's lymphoma (serious criteria GSK medically significant). The patient was treated with infliximab (Remicade), immunoglobulins nos (Ivig) and prednisone. On an unknown date, the outcome of the non-hodgkin's lymphoma was not recovered/not resolved.   It was unknown if the reporter considered the non-hodgkin's lymphoma to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix with non hodkin lymphoma had received several treatments (among those, Remicade, IVIG, prednisone). The primary care physician recommended the patient to avoid getting the second dose of Shingrix.  The other health professional could not provide date for first dose given and first line agent did not clarify if the diagnose was before or after the first dose this cannot be discarded. The reporter did not consent to follow-up.
Red circle around injection site, approximately 2 inches in diameter; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 3-year-old patient received BNT162b2 (BNT162B2), on 22Jul2022 at 18:00 as dose 2, single (Lot number: FL8094) at the age of 3 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Seasonal allergies" (unspecified if ongoing). Concomitant medication(s) included: CLARITINE. Vaccination history included: BNT162b2 (DOSE 1,SINGLE; Batch/Lot No: FL8095; Anatomical location: Arm Left; Administration Time: 05:30 PM), administration date: 01Jul2022, when the patient was 3-year-old, for COVID-19 Immunization. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious) with onset 23Jul2022 at 12:00, outcome "not recovered", described as "Red circle around injection site, approximately 2 inches in diameter". Therapeutic measures were not taken as a result of vaccination site erythema.  Additional information:  The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the prior to the COVID-19 vaccine. Other medications received in two weeks were claritin, elderberry gummies.The patient was not tested for COVID-19 post vaccination.
Patient started feeling "lightheaded" and then felt as if hands were shaking. NO visible shaking noted. Feeling dissapeared within about two minutes.
Patient started to develop chest pain, shortness of breath, cough approximately 3 days to 1 week following second covid vaccination.  This continued to get progressively worse prompting visit to PCP on 4/7/21.  Initially conservative treatment  with medication for allergies and asthma didn't help.   Symptoms worsened and led to a second visit with PCP on 5/17/21 where patient was sent over to the ER for additional evaluation.  CT of the chest revealed bilateral pleural effusions, evidence of air trapping and bronchial wall thickening.  Patient diagnosed with pleurisy, pleural effusions.   She is still undergoing treatment with pulmonary and is started on furosemide, prednisone, inhalers.  She continues to be short of breath and may be required to be out of work for as long as 4 months as per the pulmonologist.
Information has been received from a physician concerning an around 14 year old female who was vaccinated IM with her first dose of GARDASIL and then "passed out". After fifteen minutes, the patient recovered. The patient did not seek medical attention. No further information is available.
I fell an used my hands to break my fall. I have osteoporosis, this may have been what helped to make the break to my wrist much worse. I went to the local emergency they did x-rays and discovered the break was much more complicated than they could handle. I was sent to a hospital that specializes is complicated bone fractures. Upon my arrival to the specialty hospital they took new x-rays. I was given an epidural from the neck down; my wrist bones were cut open and I had a bone marrow implant placed. I have a plaster cast currently; I do have feeling in my fingers now.
On 8/26/2022 patient was due for Pentacel, PCV13, and Rotavirus vaccinations. Vaccination orders were verbally conveyed to medical assistant as well as indicated on patient information sheets per office protocol. Vaccinations logged into patient's chart by medical assistant as Pentacel, PCV13, and Rotavirus on day of visit. Patient received Pentacel and PCV13 as ordered. However,, 8/29/22, it was reported to this physician by the office manager that diluting agent for Rotavirus was in error combined with MenQuadfi vaccine. Diluting agent mixed with MenQuadfi subsequently provided to patient PO.  Parents report ~3 days of fussiness s/p vaccinations. Return to baseline health after these ~3 days of fussiness.